-
-
-
-
-
-
-
BioNTech (BNTX) PT Raised to $140 at H.C. Wainwright
-
-
-
-
-
-
-
BioNTech SE (BNTX) Tops Q1 EPS by 27c
-
-
-
-
-
-
-
Pfizer and BioNTech Receive U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vaccine
-
-
-
-
-
-
-
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the European Union
-
-
-
-
-
-
-
BioNTech SE (BNTX) Misses Q4 EPS by 46c, Misses on Revenue; Offers FY24 Revenue Guidance
-
-
-
-
-
-
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against BioNTech, Mobileye, BioVie, and ADM and Encourages Investors to Contact the Firm
-
-
-
-
-
-
-
BIONTECH INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In BioNTech To Contact Him Directl
-
1,216,208 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

